Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Glenmark Pharmaceuticals Limited
Press Release Sep 05 2025
Business
Sep 5 2025
5 min read

Press Release Sep 05 2025

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 05, 2025, titled "Glenmark Initiates a Multi-Country Phase 3 Clinical Trial for Envafolimab in Resectable Stage III Non-Small Cell Lung Cancer".

View Attachment